The success of antibody-drug conjugates illustrates the value of targeted delivery strategies for cytotoxic molecules. We present a novel approach to targeted delivery that uses intracellular covalent chemistry to selectively activate cytotoxins.
Schild et al. (Thu,) studied this question.